Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "future ventures ipo"

Electric Vehicle manufacturer Mullen Technologies, Inc. gearing up to compete with Tesla and Faraday Future with expanding group of experts
Tutorial Finder

Electric Vehicle Manufacturer Mullen Technologies, Inc. Gearin...

BENICIA, Calif.--( BUSINESS WIRE )--Mullen Technologies, Inc., a pre-IPO car manufacturer and distributor, has announced the hiring of Mr. Paul Saluzzi as Chief Operating Officer. Mr. Saluzzi is a 20-year veteran of the financial industry, most ... Business Wire, 2 weeks ago

ShopClues gets fresh fund, valuation rises to $1.1 bn

e e-commerce marketplace says this was its last round of fund raising and its future plans include an IPO. Shopclues, the e-commerce marketplace focused on budget customers in Tier-II and Tier-III cities on Tuesday said its valuation rose to $1.1 ...
 Agencyfaqs!3 weeks ago

Editas Medicine, Backed By Google And Bill Gates, Files $100 Million IPO

Editas Medicine, a Cambridge, Massachusetts-based drugmaker backed by Bill Gates and Google Ventures among others, filed its initial public offering paperwork on Monday. The company specializes in a new gene-editing technique called Crispr, and will ...
 Benzinga.com1 month ago Editas Medicine prepping for IPO even as biotech market struggles  BioPharma Dive1 week ago

Gene-Editing Drugmaker Backed by Google, Gates Files for IPO

Editas Medicine Inc., the drugmaker whose backers include Bill Gates and Google Ventures, filed to become the first publicly traded company to specialize in a new technology to edit flaws in genes. The company, which uses a gene-editing technique ...
 Bloomberg1 month ago Editas, gene-editing drugmaker backed by Google, files for IPO  San Francisco Chronicle1 month ago

SLM Solutions concludes agreement in principle on joint venture to enter powder business

. - Signing of legally binding term sheet for joint venture formation with PKM Future Holding GmbH - Strategic cooperation in development, production, distribution of metallic powders - Aluminium powder business to supplement system business as ...
 Presse Box6 days ago

Moving On Up: Monroe Capital's Rise, New Venture and Promising Future

By Phil Neuffer As Monroe Capital enters its second decade in business, president and CEO Ted Koenig looks back at the challenges of the Great Recession and shares his vision for a bright future. In 2004, when Ted Koenig set out to ...
 ABF Journal2 weeks ago

Hercules Announces Q4 Portfolio Update and Select Achievements for 2015

. (NYSE:HTGC), the leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced its Q4 2015 portfolio update and select achievements for 2015. 2015 was ...
 Wall Street Select3 weeks ago
Pensions and Investments Online

Venture capital investments could be victim of own success

Venture capital has, for many endowments, been the best performing asset class in recent years. That's the good news. But because of those outsize returns, in part, some endowments' venture capital portfolios now exceed their target ...
 Pensions and Investments Online11 hours ago Venture capital predictions for 2016  Yahoo! Finance1 week ago How Venture Capital Will Change in 2016  Investopedia1 week ago Intel Capital's secret sauce: Invest early and look to the East  ZDNet1 week ago

LONDON BRIEFING: CMC Markets Gets IPO Away At Low End Of Price Range

LONDON (Alliance News) - London shares were firm at the open Friday, with the day's economic data focus to be US non-farm payrolls in the afternoon. Spread betting firm CMC Markets got its initial public offering away, but priced the shares towards ...
 London Stock Exchange3 days ago LONDON MARKET MIDDAY: Pound Rises After Upbeat UK Service Sector Data  London Stock Exchange5 days ago

Crispr Gene-Editing Upstart Editas Goes Public as Patent Battle Rages

The future of medicine may rest in altering our genes. That's a constant refrain in the recent history of medical science. Over the past few decades, researchers and investors have pinned their hopes on experimental gene therapies with the potential ...
 Wired News4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less